Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.
Saved in:
| Title: | Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer. |
|---|---|
| Authors: | Horvat NK; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Saint-Cloud M; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Bint Abdullah Muslim R; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Tian Y; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodriguez BL; The Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Pathology and Laboratory Medicine, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hall MA; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Labani-Motlagh A; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Diao L; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lesinski GB; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia., Moffitt RA; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia.; Department of Biomedical Informatics, Emory University, Atlanta, Georgia., Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konen JM; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2026 Jun 02; Vol. 14 (6), pp. 974-991. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
